Exclusive

Publication

Byline

Emcure Pharmaceuticals to expand gynaecology, derma portfolio for India market in FY26

New Delhi, May 22 -- Pune-headquartered Emcure Pharmaceuticals plans to expand its gynaecology and dermatology product portfolio for the Indian market in FY26, the company's top executive said on Thur... Read More


Zydus bets big on vaccines and medtech

Mumbai, May 21 -- Zydus Lifesciences Ltd is looking to ramp up its vaccines and medtech portfolio over the next few years, the company's top executive told investors during an earnings call Tuesday ev... Read More


IHH Healthcare arm increases damages sought from Daiichi Sankyo to Rs.11,800 crore over Fortis stake dispute

New Delhi, May 20 -- IHH Healthcare's indirect subsidiary Northern TK Venture Pte Ltd (NTK) has increased its damages claim against Japanese pharma company Daiichi Sankyo Co. about tenfold to Rs.11,80... Read More


Access to obesity management not available to most Indian patients: World Heart Federation report

Mumbai, May 18 -- Obesity in India has risen tremendously in the last 35 years, in tandem with rising rates across the world, a new report highlights, and tools to manage obesity are not universally a... Read More


US tailwinds, AI investments, to drive growth for IKS Health

New Delhi, May 16 -- Jhunjhunwala family-backed Inventurus Knowledge Solutions (IKS) aims to grow faster than the market in FY26 with more investments in artificial intelligence (AI), improving synerg... Read More


Piramal Pharma to see muted CDMO growth on US jitters; strong recovery in FY27

New Delhi, May 15 -- Piramal Pharma anticipates muted, single-digit growth for its contract development and manufacturing organization (CDMO) business in FY26, hurt by near-term uncertainties as clien... Read More


Piramal Pharma CDMO growth hit by US policy jitters; recovery seen in FY27

New Delhi, May 15 -- Piramal Pharma anticipates muted, single-digit growth for its contract development and manufacturing organization (CDMO) business in FY26, hurt by near-term uncertainties as clien... Read More


Don't expect immediate impact of US tariff threat, price cuts on business, says Cipla head

New Delhi, May 13 -- Cipla does not expect any immediate impact from potential tariffs imposed by the US on pharmaceutical imports or from US President Trump's recent order to bring down prescription ... Read More


Biocon sees mid-teens revenue growth on biosimilars, generics push

New Delhi, May 13 -- Biocon Ltd expects its overall revenue to grow in mid-teens this financial year, and the company is betting on a robust launch pipeline in its generics as well as biosimilars busi... Read More


Biocon to evaluate merger with subsidiary Biologics

New Delhi, May 12 -- Biocon Group's board is setting up a committee to evaluate strategic restructuring options, including a merger of its biosimilars arm Biocon Biologics Ltd with its flagship Biocon... Read More